I recently came across the following report:
http://med.stanford.edu/news/all-news/20...entia.html
Summary: based on mining records of prostate cancer patients, the authors detected an increased risk of dementia (from 3.5% to 7.9%) in patients who received anti-androgens. However, they advise against suddenly stopping or changing clinical care, and recommend that further research is required. They don't suggest whether this applies to patients without cancer, and whether it's AAs in general, specific AAs, or low testosterone that had this effect.
Just something to keep in mind.
http://med.stanford.edu/news/all-news/20...entia.html
Summary: based on mining records of prostate cancer patients, the authors detected an increased risk of dementia (from 3.5% to 7.9%) in patients who received anti-androgens. However, they advise against suddenly stopping or changing clinical care, and recommend that further research is required. They don't suggest whether this applies to patients without cancer, and whether it's AAs in general, specific AAs, or low testosterone that had this effect.
Just something to keep in mind.